Home › Funds › FRED ALGER MANAGEMENT, LLC › RGEN

FRED ALGER MANAGEMENT, LLC position in RGEN

REPLIGEN CORP · Health Care

FRED ALGER MANAGEMENT, LLC reported holding 733,739 shares of RGEN (REPLIGEN CORP) in its Q2 2026 13F filing — a position valued at US$100.1M, representing 0.33% of its reported portfolio and ranking #43 among its reported holdings. FRED ALGER MANAGEMENT, LLC has disclosed RGEN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)733.74K sh
Reported value held$100.11M
Portfolio Weight0.33%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FRED ALGER MANAGEMENT, LLC's RGEN position evolved

FRED ALGER MANAGEMENT, LLC first disclosed a stake in RGEN in Q3 2023 at 484,722 shares (US$77.1M). The position peaked in Q4 2025 at 911,527 shares, worth US$149.4M. Across 12 filings, FRED ALGER MANAGEMENT, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 733,739 shares valued at US$100.1M — an increase of 298,965 shares quarter over quarter.. Notable position changes include a 154% increase in Q4 2025 (shares fell 28% over the following quarter), a 52% trim in Q1 2026 (shares rose 16% over the following quarter), a 69% increase in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 484.72K $77.08M New
Q4 2023 428.48K $77.04M Reduce
Q1 2024 426.29K $78.40M Reduce
Q2 2024 307.72K $38.79M Reduce
Q3 2024 398.55K $59.31M Add
Q4 2024 359.51K $51.75M Reduce
Q1 2025 437.04K $55.61M Add
Q2 2025 299.56K $37.26M Reduce
Q3 2025 358.42K $47.91M Add
Q4 2025 911.53K $149.36M Add
Q1 2026 434.77K $51.23M Reduce
Q2 2026 733.74K $100.11M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 32 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has FRED ALGER MANAGEMENT, LLC held RGEN?

FRED ALGER MANAGEMENT, LLC has disclosed RGEN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is FRED ALGER MANAGEMENT, LLC's current position in RGEN?

As of Q2 2026, FRED ALGER MANAGEMENT, LLC holds 733.74K shares of RGEN (REPLIGEN CORP), valued at $100.11M, representing 0.33% of its reported portfolio and ranking #43.

Has FRED ALGER MANAGEMENT, LLC been buying or selling RGEN?

In the latest 13F filing (Q2 2026), FRED ALGER MANAGEMENT, LLC increased its position in RGEN. The position peaked in Q4 2025 at 911.53K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.